{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:20:51Z","timestamp":1781929251625,"version":"3.54.5"},"reference-count":28,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T00:00:00Z","timestamp":1200873600000},"content-version":"vor","delay-in-days":3825,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold>The prognostic value of cytogenetic classification in acute lymphoblastic leukaemia (ALL) was evaluated in Swedish children below 16 years of age (<jats:italic>n<\/jats:italic>= 372) diagnosed between 1986 and 1991. A bone marrow karyotype was obtained in 281 cases, of which 149 (53%) showed clonal abnormalities. Event\u2010free survival (p\u2010EFS) was 0.64\u20130.69 in patients with diploid and pseudodiploid karyotype. Patients with massive hyperdiploidy (&gt; 50 chromosomes) had the best outcome (p\u2010EFS = 0.76) and those with hypodiploidy (&lt; 46 chromosomes) had the worst (p\u2010EFS = 0.33). White blood cell count and age were the strongest predictors of outcome. The karyotype reached borderline significance. The diagnostic karyotype was also a predictor of outcome after relapse, with hyperdiploid patients doing better than the others. The presence of a structural chromosomal abnormality did not constitute a negative prognostic factor when intensive chemotherapy was given.<\/jats:p>","DOI":"10.1111\/j.1651-2227.1997.tb08604.x","type":"journal-article","created":{"date-parts":[[2010,8,7]],"date-time":"2010-08-07T02:49:53Z","timestamp":1281149393000},"page":"819-825","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986\u201091"],"prefix":"10.1111","volume":"86","author":[{"given":"E","family":"Forestier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"von Heideman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hernell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Mitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Nordenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Swolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"S\u00f6derh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,21]]},"reference":[{"key":"e_1_2_1_1_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322407"},{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199501000-00006"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6151.1529"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V60.4.864.864"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.8.1449.1449"},{"key":"e_1_2_1_6_2","volume-title":"An international system for human cytogenetic nomenclature","author":"ISCN","year":"1985"},{"key":"e_1_2_1_7_2","volume-title":"SPSS statistical software","author":"Nourusis MJ.","year":"1994"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox DR.","year":"1972","journal-title":"J Royal Stat Soc (B)"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.12.2183"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199122000-00017"},{"key":"e_1_2_1_11_2","first-page":"10","article-title":"Collaborative study of karyotypes in childhood acute lymphoblastic leukemias","volume":"7","author":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_1_12_2","first-page":"185","article-title":"Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia","volume":"6","author":"Heerema NA","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_1_13_2","first-page":"213","article-title":"Heterogeneity of hyper\u2010diploid (51\u201367) childhood acute lymphoblastic leukemia","volume":"10","author":"Raimondi SC","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.4.606"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood.V79.12.3245.3245","article-title":"Hyperdiploid (47\u201350) acute lymphoblastic leukemia in children","volume":"79","author":"Raimondi SC","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.5.1079.1079"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V80.5.1316.1316","article-title":"Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (50 chromosomes) B\u2010lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study","volume":"80","author":"Whitehead VM","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_18_2","first-page":"163","article-title":"Prognostic implication of hyperdiploidy as based on DNA flow cytometric measurement in childhood acute lymphocytic leukemia\u2010a multicenter study","volume":"1","author":"Smets LA","year":"1987","journal-title":"Leukemia"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900915)66:6<1183::AID-CNCR2820660618>3.0.CO;2-P"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.12.3316.3316"},{"key":"e_1_2_1_21_2","first-page":"171","article-title":"Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemia","volume":"3","author":"Raimondi SC","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_1_22_2","first-page":"373","article-title":"A NOPHO study. Down's syndrome (DS) and acute myelogenous leukemia (AML). A population based study in the five Nordic countries","volume":"20","author":"Sl\u00f8rdahl SH","year":"1992","journal-title":"Med Pediatr Oncol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood.V73.7.1963.1963","article-title":"Prognostic importance of structural abnormalities in children with hyperdiploid (50 chromosomes) acute lymphoblastic leukemia","volume":"73","author":"Pui C\u2010H","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.6.2130.2130"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(91)90224-I"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood.V82.2.576.576","article-title":"Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia","volume":"82","author":"Raimondi SC","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_27_2","first-page":"1289","article-title":"Treatment of acute lymphoblastic leukemia","volume":"329","author":"Rivera GK","journal-title":"N Engl J Med YEAR"},{"key":"e_1_2_1_28_2","first-page":"703","article-title":"The non\u2010random die (9:12) translocation in acute lymphoblastic leukemia is associated with B\u2010progenitor phenotype and exellent prognosis","volume":"6","author":"Mahmond H","year":"1992","journal-title":"Leukemia"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.1997.tb08604.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.1997.tb08604.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:42:06Z","timestamp":1740350526000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.1997.tb08604.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1111\/j.1651-2227.1997.tb08604.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.1997.tb08604.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]},"assertion":[{"value":"2008-01-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}